Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-048-24
Published April 5, 2017 · Recall initiated: March 10, 2017
Summary
FDA records drug Class II recall D-0615-2017, published April 5, 2017 and initiated March 10, 2017. Recalling firm: Claris Lifesciences Inc; Status: Terminated; Reported quantity: 24,456 units (1019 cartons x 24 bags); Lot: Lot #: A060040, Exp. Dec 2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
What to do
Voluntary: Firm initiated · Letter
Get an email if LEVOFLOXACIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LEVOFLOXACIN
- Manufacturer
- Claris Lifesciences Inc
- Distributor
- Nationwide
- UPC
- 0336000047241
- Lot
- Lot #: A060040, Exp. Dec 2017
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevofloxacin Tablets, 500 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-6352-61June 15, 2022
- FDALevofloxacin Injection in 5% Dextrose 500 mg in 100 mL 5% Dextrose (5 mg/mL) 24x100 mL Single Dose FlexibleJune 2, 2021
- FDALevofloxacin Injection in 5% Dextrose, 5 mg/mL, packaged in a) 50 mL (NDC 36000-046-24), b) 100 mL (NDCOctober 3, 2018
- FDALevofloxacin Injection in 5% Dextrose, 250 mg (5 mg/mL), 250 mg in 50 mL 5% Dextrose, 50 mL Single UseAugust 15, 2018
- FDAFluconazole Injection, USP, 400 mg in 200 mL, Rx only, Manufactured for: Claris Lifesciences Inc. NorthApril 5, 2017
- FDAMetronidazole Injection, USP, 500 mg/100 mL, Rx only, Manufactured for: Claris Lifesciences Inc. NorthApril 5, 2017
Questions about this recall
Was Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-048-24 recalled?
Yes. FDA published recall D-0615-2017 on April 5, 2017. Reported hazard: Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LEVOFLOXACIN. UPC: 0336000047241.